Tamoxifen, a partial competitive anatgonist to the estrogen receptor, is a potent ainhibitor of the proliferation of experimental mammary carcinoma in the rat and is widely used clinically in the treatment of breast cancer.[...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
Antiestrogens are widely used in the management of hormonally responsive breast cancer in both adjuv...
There is now strong evidence to suggest that insulin-like growth factor I (IGF-I) plays an important...
Somatostatin (SST) inhibition of hormone hypersecretion from tumors is mediated by somatostatin rece...
Background: Steroid receptor coactivators (SRCs) may modulate estrogen receptor (ER) activity and th...
Mammary hyperplasia increases breast cancer risk. Tamoxifen prevents breast cancer in women with aty...
Tamoxifen is the most often prescribed non steroidal antioestrogenic agent in the world for breast c...
We have established a female Noble rat model to explore the mechanisms of hormonal mammary carcinoge...
Epidemiological and experimental evidences strongly support the role of estrogens in breast tumor de...
The MXT mouse mammary carcinoma is a new transplantable tumour which contains significant amounts of...
Mammary hyperplasia increases breast cancer risk. Tamoxifen prevents breast cancer in women with at...
The importance of systemic reproductive hor-mones inmammary gland development and breast cancer has ...
Upon activation by estrogen, the Estrogen Receptor binds the chromatin and influ...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
Antiestrogens are widely used in the management of hormonally responsive breast cancer in both adjuv...
There is now strong evidence to suggest that insulin-like growth factor I (IGF-I) plays an important...
Somatostatin (SST) inhibition of hormone hypersecretion from tumors is mediated by somatostatin rece...
Background: Steroid receptor coactivators (SRCs) may modulate estrogen receptor (ER) activity and th...
Mammary hyperplasia increases breast cancer risk. Tamoxifen prevents breast cancer in women with aty...
Tamoxifen is the most often prescribed non steroidal antioestrogenic agent in the world for breast c...
We have established a female Noble rat model to explore the mechanisms of hormonal mammary carcinoge...
Epidemiological and experimental evidences strongly support the role of estrogens in breast tumor de...
The MXT mouse mammary carcinoma is a new transplantable tumour which contains significant amounts of...
Mammary hyperplasia increases breast cancer risk. Tamoxifen prevents breast cancer in women with at...
The importance of systemic reproductive hor-mones inmammary gland development and breast cancer has ...
Upon activation by estrogen, the Estrogen Receptor binds the chromatin and influ...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prev...
DOI
Add to ORKG